JP2001504828A5 - - Google Patents

Download PDF

Info

Publication number
JP2001504828A5
JP2001504828A5 JP1998523502A JP52350298A JP2001504828A5 JP 2001504828 A5 JP2001504828 A5 JP 2001504828A5 JP 1998523502 A JP1998523502 A JP 1998523502A JP 52350298 A JP52350298 A JP 52350298A JP 2001504828 A5 JP2001504828 A5 JP 2001504828A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998523502A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001504828A (ja
Filing date
Publication date
Priority claimed from EP96203234A external-priority patent/EP0842657A1/en
Application filed filed Critical
Priority claimed from PCT/NL1997/000625 external-priority patent/WO1998022093A1/en
Publication of JP2001504828A publication Critical patent/JP2001504828A/ja
Publication of JP2001504828A5 publication Critical patent/JP2001504828A5/ja
Ceased legal-status Critical Current

Links

JP52350298A 1996-11-19 1997-11-17 制御型放出システムの調製方法 Ceased JP2001504828A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96203234.8 1996-11-19
EP96203234A EP0842657A1 (en) 1996-11-19 1996-11-19 Microspheres for controlled release and processes to prepare these microspheres
PCT/NL1997/000625 WO1998022093A1 (en) 1996-11-19 1997-11-17 Process for the preparation of a controlled release system

Publications (2)

Publication Number Publication Date
JP2001504828A JP2001504828A (ja) 2001-04-10
JP2001504828A5 true JP2001504828A5 (https=) 2004-09-02

Family

ID=8224598

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52350298A Ceased JP2001504828A (ja) 1996-11-19 1997-11-17 制御型放出システムの調製方法

Country Status (3)

Country Link
US (1) US6303148B1 (https=)
EP (1) EP0842657A1 (https=)
JP (1) JP2001504828A (https=)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395302B1 (en) * 1996-11-19 2002-05-28 Octoplus B.V. Method for the preparation of microspheres which contain colloidal systems
NZ502358A (en) * 1997-07-18 2002-11-26 Infimed Therapeutics Inc Hydrogel composition comprising a biologically active substance combined with a macromer
ATE364374T1 (de) 1997-08-11 2007-07-15 Pfizer Prod Inc Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit
WO1999055396A1 (en) 1998-04-27 1999-11-04 Surmodics, Inc. Bioactive agent release coating
EP1074248A1 (en) * 1999-07-08 2001-02-07 Arnold Hilgers Delivery system for biological material
US6699470B1 (en) * 1999-10-12 2004-03-02 Massachusetts Institute Of Technology Mesh-gel constructs for cell delivery containing enzymes and/or enzyme inhibitors to control gel degradation
US6805879B2 (en) * 2000-06-23 2004-10-19 Biopharm Solutions Inc. Stable polymer aqueous/aqueous emulsion system and uses thereof
EP1306127B2 (en) * 2001-10-26 2011-09-07 OctoPlus PolyActive Sciences B.V. Method for the preparation of purified microparticles
CA2822457C (en) * 2001-12-14 2016-03-08 The University Of Wyoming Methods and compositions for controlled resease of drugs
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
EP1393718A1 (en) * 2002-08-29 2004-03-03 OctoPlus Sciences B.V. Colloidal drug carrier system
EA200501422A1 (ru) * 2003-03-04 2006-04-28 Дзе Текнолоджи Девелопмент Компани Лтд. Длительнодействующая инъецируемая композиция инсулина и способы её изготовления и применения
US8545830B2 (en) * 2003-03-24 2013-10-01 University Of Tennessee Research Foundation Multi-functional polymeric materials and their uses
TWI293317B (en) * 2003-12-31 2008-02-11 Ind Tech Res Inst Method for preparing polymer microspheres by aqueous phase-aqueous phase emulsion process
EP1576952A1 (en) * 2004-03-18 2005-09-21 OctoPlus Technologies B.V. Hydrogel microspheres with improved release profile
US20050220841A1 (en) 2004-04-06 2005-10-06 Dewitt David M Coating compositions for bioactive agents
JP5026956B2 (ja) * 2004-05-12 2012-09-19 サーモディクス,インコーポレイティド 医療用具のための天然生分解性多糖コーティング
US20070258939A1 (en) * 2004-08-03 2007-11-08 Biocamparibles Uk Limited Drug Delivery from Embolic Agents
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
US20060141021A1 (en) * 2004-12-29 2006-06-29 Industrial Technology Research Polymeric microspheres and method for preparing the same
US8932633B2 (en) * 2005-08-29 2015-01-13 Biopharm Solutions Inc. Polysaccharide microparticles containing biological agents: their preparation and applications
CA2621595A1 (en) * 2005-09-21 2007-04-12 Surmodics, Inc. Coatings and articles including natural biodegradable polysaccharides
ATE454908T1 (de) * 2005-09-21 2010-01-15 Surmodics Inc In situ okklusionszusammensetzungen mit natürlichen biologisch abbaubaren polysacchariden
EP1929073A4 (en) * 2005-09-27 2010-03-10 Amunix Inc PROTEIN MEDICAMENT AND ITS USE
US7846445B2 (en) * 2005-09-27 2010-12-07 Amunix Operating, Inc. Methods for production of unstructured recombinant polymers and uses thereof
US7855279B2 (en) * 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
US20090099031A1 (en) * 2005-09-27 2009-04-16 Stemmer Willem P Genetic package and uses thereof
WO2007059144A1 (en) * 2005-11-15 2007-05-24 Surmodics, Inc. Ultrasonic nozzles for applying two-component coatings
WO2007061896A1 (en) 2005-11-17 2007-05-31 Zogenix, Inc. Delivery of viscous formulations by needle-free injection
JP5738516B2 (ja) 2005-12-30 2015-06-24 ゼンサン (シャンハイ) サイエンス アンド テクノロジー リミテッド 心機能改善のためのニューレグリンの徐放
US20080039931A1 (en) * 2006-04-25 2008-02-14 Surmodics, Inc. Hydrophilic shape memory insertable medical articles
WO2008003043A2 (en) * 2006-06-28 2008-01-03 Surmodics, Inc. Combination degradable and non-degradable matrices for active agent delivery
US7638344B2 (en) * 2006-06-28 2009-12-29 Surmodics, Inc. Active agent eluting matrices with particulates
US20080171087A1 (en) * 2006-08-16 2008-07-17 Chappa Ralph A Methods and materials for increasing the adhesion of elution control matrices to substrates
US20080075753A1 (en) * 2006-09-25 2008-03-27 Chappa Ralph A Multi-layered coatings and methods for controlling elution of active agents
US20080075779A1 (en) * 2006-09-27 2008-03-27 Chappa Ralph A Additives And Methods For Enhancing Active Agent Elution Kinetics
WO2008058349A1 (en) * 2006-11-17 2008-05-22 Gareth Michael Forde Materials, methods and systems for purification and/or seperation
US20080154241A1 (en) * 2006-12-07 2008-06-26 Burkstrand Michael J Latent stabilization of bioactive agents releasable from implantable medical articles
CN100471542C (zh) * 2006-12-15 2009-03-25 中国科学院长春应用化学研究所 一种分离超细微粒的工艺
US8821899B2 (en) * 2007-03-12 2014-09-02 Board Of Regents, The University Of Texas System Method and process for the production of multi-coated recognitive and releasing systems
US8771713B2 (en) * 2007-03-12 2014-07-08 Board Of Regents, The University Of Texas System Method and process for the production of multi-coated recognitive and releasing systems
US9155703B2 (en) * 2007-03-12 2015-10-13 Board Of Regents, The University Of Texas System Method and process for the production of multi-coated recognitive and releasing systems
US8741316B2 (en) * 2007-03-12 2014-06-03 Board Of Regents, The University Of Texas System Highly porous, recognitive polymer systems
WO2008121750A2 (en) * 2007-03-28 2008-10-09 Vance Products Incorporated D/B/A Medical device for delivering a bioactive and method of use thereof
EP2143446B1 (en) 2007-05-01 2019-07-24 National University Corporation Tokyo Medical and Dental University Hybrid gel comprising chemically crosslinked hyaluronic acid derivative and pharmaceutical composition comprising the same
EP2025334A1 (en) * 2007-07-25 2009-02-18 OctoPlus Sciences B.V. Sustained release drug delivery system for repeated administration
US8933197B2 (en) * 2007-08-15 2015-01-13 Amunix Operating Inc. Compositions comprising modified biologically active polypeptides
US20090214601A1 (en) * 2007-09-28 2009-08-27 Chappa Ralph A Porous Drug Delivery Devices and Related Methods
WO2009091812A2 (en) * 2008-01-14 2009-07-23 Surmodics, Inc. Devices and methods for elution of nucleic acid delivery complexes
US7748452B2 (en) * 2008-02-19 2010-07-06 Schlumberger Technology Corporation Polymeric microspheres as degradable fluid loss additives in oilfield applications
US8951545B2 (en) 2008-03-28 2015-02-10 Surmodics, Inc. Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery
US20090263449A1 (en) * 2008-04-09 2009-10-22 Surmodics, Inc. Delivery of nucleic acid complexes from materials including negatively charged groups
AU2009241847B2 (en) 2008-04-28 2014-07-10 Zogenix, Inc. Novel formulations for treatment of migraine
JP5763525B2 (ja) * 2008-05-07 2015-08-12 サーモディクス,インコーポレイティド 粒子からの核酸複合体の送達
JP2011528038A (ja) * 2008-07-14 2011-11-10 サーモディクス,インコーポレイテッド 医療用デバイスおよび核酸の送達方法
CA2748314C (en) 2009-02-03 2018-10-02 Amunix Operating Inc. Extended recombinant polypeptides and compositions comprising same
WO2010102065A1 (en) 2009-03-05 2010-09-10 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives
WO2010111132A2 (en) 2009-03-27 2010-09-30 Bend Research, Inc. Spray-drying process
US20110046721A1 (en) * 2009-08-10 2011-02-24 Surmodics, Inc. Biodegradable Metal-Polymer Composite Constructs For Implantable Medical Devices
AU2010290131C1 (en) 2009-08-24 2015-12-03 Amunix Operating Inc. Coagulation factor VII compositions and methods of making and using same
NZ599543A (en) 2009-10-30 2014-02-28 Ntf Therapeutics Inc Improved neurturin molecules
US20110159098A1 (en) * 2009-12-30 2011-06-30 Surmodics, Inc. Stabilization and delivery of nucleic acid complexes
WO2012003293A1 (en) 2010-06-30 2012-01-05 Surmodics, Inc. Lipid coating for medical devices delivering bioactive agent
US9084976B2 (en) 2010-09-03 2015-07-21 Bend Research, Inc. Spray-drying apparatus and methods of using the same
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
US20120100187A1 (en) 2010-10-26 2012-04-26 Surmodics, Inc. Coatings and methods for controlled elution of hydrophilic active agents
US8901092B2 (en) 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
US9084727B2 (en) 2011-05-10 2015-07-21 Bend Research, Inc. Methods and compositions for maintaining active agents in intra-articular spaces
BR112014020694A2 (pt) 2012-02-15 2018-05-08 Amunix Operating Inc. proteína de fusão do fator viii compreendendo polipeptídeo do fator viii fusionado a polipeptí-deo recombinante estendido (xten) e seu método de fabricação, ácido nucleico, vetores, célula hospedeira, bem como composição farmacêutica e seu uso no tratamento de coagulopatia, episódio de hemorragia e hemofilia a
CA2864126A1 (en) 2012-02-15 2013-08-22 Biogen Idec Ma Inc. Recombinant factor viii proteins
US9827401B2 (en) 2012-06-01 2017-11-28 Surmodics, Inc. Apparatus and methods for coating medical devices
CA2874824C (en) 2012-06-01 2021-10-26 Surmodics, Inc. Apparatus and methods for coating balloon catheters
US11090468B2 (en) 2012-10-25 2021-08-17 Surmodics, Inc. Apparatus and methods for coating medical devices
US10548953B2 (en) 2013-08-14 2020-02-04 Bioverativ Therapeutics Inc. Factor VIII-XTEN fusions and uses thereof
US10004753B2 (en) 2015-01-16 2018-06-26 The J. David Gladstone Institutes Methods for treating tauopathy
CN117503939A (zh) 2015-07-13 2024-02-06 考司美德制药株式会社 药物缓释载体及制备方法
BR112018002150A2 (pt) 2015-08-03 2018-09-18 Bioverativ Therapeutics Inc proteínas de fusão do fator ix e métodos de fabricação e uso das mesmas
EP4480544A3 (en) 2015-08-25 2025-03-26 Babita Agrawal Immunomodulatory compositions andmethods of use thereof
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
EP3205393A1 (en) 2016-02-12 2017-08-16 Basf Se Process for preparation of microcapsules
US10712240B2 (en) 2016-04-19 2020-07-14 Ariana Schanzer Contaminant monitor system and method
RU2018145364A (ru) 2016-06-27 2020-07-28 Ачиллион Фармасьютикалс, Инк. Хиназолиновые и индольные соединения для лечения медицинских нарушений
IL319473A (en) 2016-12-02 2025-05-01 Bioverativ Therapeutics Inc Methods for treating hemophilic arthritis using chimeric blood clotting factors
CN110603252A (zh) 2017-03-01 2019-12-20 艾其林医药公司 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物
BR112020022164A2 (pt) 2018-05-18 2021-02-02 Bioverativ Therapeutics Inc. métodos de tratamento de hemofilia a
WO2020041301A1 (en) 2018-08-20 2020-02-27 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
WO2020051532A2 (en) 2018-09-06 2020-03-12 Achillion Pharmaceuticals, Inc. Macrocyclic compounds for the treatment of medical disorders
EP3866773B1 (en) 2018-10-16 2024-08-28 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
WO2020112816A1 (en) 2018-11-29 2020-06-04 Surmodics, Inc. Apparatus and methods for coating medical devices
US11819590B2 (en) 2019-05-13 2023-11-21 Surmodics, Inc. Apparatus and methods for coating medical devices
CN119837855A (zh) 2019-12-19 2025-04-18 乔治亚州大学研究基金会 用于治疗细菌感染和增强抗生素的化合物
WO2021168320A1 (en) 2020-02-20 2021-08-26 Achillion Pharmaceuticals, Inc. Heteroaryl compounds for treatment of complement factor d mediated disorders
WO2022066774A1 (en) 2020-09-23 2022-03-31 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement mediated disorders
US12496612B2 (en) 2021-01-08 2025-12-16 Surmodics, Inc. Coating application system and methods for coating rotatable medical devices
CN115109301A (zh) * 2021-03-18 2022-09-27 四川大学 一种中空开口二醋酸纤维素微球的制备方法
WO2025111713A1 (en) * 2023-12-01 2025-06-05 Tsai Scott S H Systems and methods of isolation of extracellular vesicles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
SE459005B (sv) * 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
US5603955A (en) * 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
IT1268718B1 (it) * 1994-07-26 1997-03-06 Fidia Advanced Biopolymers Srl Sintesi di gel chimici da polisaccaridi polielettroliti tramite gamma irradiazione
US5827707A (en) * 1995-06-07 1998-10-27 Neocrin Company Method for manufacturing minimal volume capsules containing biological materials
US5980948A (en) * 1996-08-16 1999-11-09 Osteotech, Inc. Polyetherester copolymers as drug delivery matrices

Similar Documents

Publication Publication Date Title
JP2000502280A5 (https=)
JP2000506265A5 (https=)
JP2000501771A5 (https=)
JP2000513333A5 (https=)
JP2000500076A5 (https=)
JP2002514124A5 (https=)
JP2000507053A5 (https=)
JP2000500055A5 (https=)
JP2001505855A5 (https=)
JP2000502472A5 (https=)
JP2000501825A5 (https=)
JP2001511697A5 (https=)
JP2000500874A5 (https=)
JP2000517102A5 (https=)
JP2000502425A5 (https=)
JP2000502485A5 (https=)
JP2000502568A5 (https=)
JP2000506908A5 (https=)
JP2000504787A5 (https=)
JP2000501774A5 (https=)
JP2000500912A5 (https=)
JP2000502570A5 (https=)
JP2000501876A5 (https=)
JP2000502316A5 (https=)
JP2000500857A5 (https=)